Articles tagged with Cardiovascular Disorders
Ochsner Health has received multiple Get with the Guidelines achievement awards for demonstrating commitment to following research-based guidelines for treating heart disease and stroke. This recognition reflects Ochsner's unwavering commitment to clinical excellence in cardiovascular care.
Research highlights importance of cardiovascular care in breast cancer patients and survivors throughout life. Cardiovascular risk factors and interventions are essential to prevent disease progression and improve quality of life.
Scientists have uncovered a new mechanism used by heart cells to resist reprogramming and found that carbohydrate sulfotransferase 7 (CHST7) is the most potent preventer of reprogramming in mouse and human cells. By targeting CHST7, researchers may develop treatments to help the heart fix itself after injury.
STS appoints Justine Varieur Turco as its new CEO/Executive Director, tasked with advancing the society's strategic priorities and improving patient outcomes in cardiothoracic surgery. With over 20 years of executive leadership experience, Turco aims to build on STS's legacy and support the specialty's continued advancement.
A large study of over 65,000 postmenopausal women found that a higher adherence to the Planetary Health Diet was associated with a 28% lower risk of cardiovascular disease. Women who followed the diet more closely had a decreased risk of heart failure and stroke compared to those in the lowest-adherence group.
A study led by Robert Koeth found a connection between elevated blood levels of TMAO, a gut bacteria byproduct, and an increased risk of atrial fibrillation. The research team discovered that TMAO changes the heart's electrical environment, making it more susceptible to abnormal rhythms.
A new study in the Canadian Journal of Cardiology predicts that generic semaglutide will dramatically increase cost-effectiveness and health system affordability for patients with type 2 diabetes and high cardiorenal risk. The estimated annual cost of providing GLP-1RAs to all indicated patients would be $3.35 to $5.31 billion at pre-g...
A new UTHealth Houston study found that women experiencing pregnancy complications are at a higher risk of developing peripheral artery disease later in life. The study analyzed data from over 2 million women in Sweden and showed that preterm delivery, preeclampsia, and other adverse outcomes can lead to increased cardiovascular risks.
Researchers analyzed data from 2,201,446 women and found associations between adverse pregnancy outcomes and an increased long-term risk of developing peripheral artery disease. Women who experience gestational diabetes, preeclampsia, or preterm delivery have a significantly increased risk of PAD later in life.
Researchers have found 17 gene variations in alpha-actinin-2 associated with hypertrophic cardiomyopathy, a leading cause of sudden cardiac death. These variations affect the protein's stability and interactions, highlighting potential targets for new treatments.
A study published in Nature Medicine found that a single daily dose of a polypill significantly enhances cardiac function and reduces hospitalizations for patients with heart failure. The treatment, which combines three types of medications, shows promise as a simplified approach to optimal therapy.
The American Heart Association states that consuming up to 400 mg of caffeine per day, equivalent to 5 cups of caffeinated coffee, is safe and may be linked to a lower risk of cardiovascular disease for some individuals. However, high doses of caffeine from energy drinks and other sources may cause cardiovascular harm.
A cross-sectional study reveals substantial commercial price variation for common cardiovascular services, influenced by payer contracting strategies and market dynamics. The findings underscore the need for greater transparency and regulatory oversight to promote efficient healthcare spending.
Patients who suffered a serious heart attack had higher levels of micro and nanoplastics in their blood compared to those with chronic ischemic heart disease and normal coronary arteries. The study also revealed that people exposed to higher levels of air pollution and smokers had higher levels of microplastics in their blood.
A new study found that adults with disabilities have more than three times the rate of alcohol use disorder diagnoses compared to adults without disabilities in the US. Adults with serious mental illness and acquired brain injuries had the highest rates of AUD, with men with disabilities having the highest rates.
A study by Rutgers researchers found that cardiovascular health during pregnancy was associated with the timing of new hypertensive and metabolic diagnoses after delivery. Women with poorer scores were diagnosed sooner than those with better scores, even without major complications.
Bradley A. Maron, MD, a renowned clinical cardiologist and researcher, has been appointed as the new editor-in-chief of Circulation. He will focus on strengthening and expanding the legacy of the journal, introducing new editorial features to publish high-quality cardiovascular science and medicine.
A study found that oxalic acid, a natural metabolic by-product, promotes inflammatory processes and contributes to cardiovascular disease in people with chronic kidney disease. Elevated levels of oxalate were detected in patients with primary hyperoxaluria and showed a link to IL-17A-mediated inflammation and cardiorenal organ damage.
A new study from the University of Copenhagen shows that exercise plays a crucial role in improving cardiovascular health even after significant weight loss. Participants who exercised developed healthier blood vessels and lower inflammation compared to those who relied on medication alone.
A global analysis found alcohol use and smoking to be common risk factors for both breast cancer and atrial fibrillation/flutter in women ages 55 and older. High-risk zones were predominantly in Western countries with greater exposure to these lifestyle risks.
New analysis reveals that most obesity medications do not meaningfully improve quality of life, cardiovascular health, or reduce mortality risk. However, some emerging drugs like tirzepatide and subcutaneous semaglutide show potential benefits in weight loss and reduced heart failure risk.
Researchers discovered a potential drug developed at Michigan Medicine reverses metabolic dysfunction-associated steatohepatitis (MASH) in animal models by disrupting the disease-driving pathway that links the gut and liver. DT-109 improved gut health, reducing inflammation in livers of nonhuman primates.
Researchers found minor cardiac dysfunction can predict microscopic tissue degradation in brain regions associated with Alzheimer's disease, leading to poor long-term memory performance.
Researchers have developed vascular organoid patches that can regenerate microvessels in the heart, leading to improved heart function and reduced progression of coronary artery disease. The patches were shown to survive for several weeks and stimulate new microvessel formation, providing a potential treatment for ischemic heart disease.
The European Association of Preventive Cardiology has published a comprehensive framework guiding cardiac evaluation in the Armed Forces. The new statement recommends cardiac screening for all new military recruits and individuals engaging in high-hazard duty occupations, including ECG-based testing and cardiovascular risk assessment.
A new study published in JAMA Network Open has found an association between cardiovascular disease risk factors and visual impairment in Hispanic/Latino adults. The research suggests that individuals with three or more risk factors, such as diabetes, high cholesterol, and hypertension, are more likely to experience visual impairment.
Expanding heart failure care to pharmacists and nurse practitioner-led medication management can save approximately 10 lives and prevent 25 hospitalizations per 1,000 patients. This service is estimated to be cost-effective and improve patient outcomes, providing a roadmap for a stronger healthcare system.
A study by the University of São Paulo found that people with diabetes who have had COVID-19 tend to recover more slowly and experience more long COVID complications, including greater physical and cognitive difficulties. The study also found a higher risk of cardiovascular complications, such as heart attacks and angina.
The updated international definition of heart failure introduces a new classification system emphasizing earlier detection and personalized treatment. The revised framework standardizes terminology, recognizing that heart failure is not a static condition.
The new calculator predicts that over 98% of people eligible for statin treatment are at low risk of serious muscle disorders. The tool aims to support informed treatment decisions by providing personalized risk estimates, helping patients and clinicians weigh benefits and risks.
A Japanese cohort study found that better maternal cardiovascular health during pregnancy is associated with lower risks of offspring developmental delay at age 4. The study suggests a potential protective effect of optimal maternal cardiovascular health on child development.
A long-term study published in Circulation found that consuming sugary drinks and fruit juice in childhood may increase the risk of developing high blood pressure later in life. The study suggests that substituting these beverages with whole fruits, milk, and water may be associated with a lower risk of developing high blood pressure.
Transcranial ultrasound stimulation (TUS) has been shown to improve gait and restore communication between cortical brain networks in mice with ischemic stroke. This treatment targets neural mechanisms that may lead to improved motor function, according to the study.
A survey of healthcare professionals revealed limited cardio-oncology training during undergraduate and postgraduate education, with only 10% reporting exposure to the subject during medical school. The study highlights the need for standardised educational programmes to address cardiovascular side effects of cancer therapies.
Researchers at the University of Zurich have developed epigenetic drugs that can reprogram perivascular fat cells to reduce inflammation and improve blood vessel health. By targeting specific gene-expression regulators, these drugs aim to prevent vascular damage in people with obesity and metabolic disease.
A meta-analysis of 14 clinical trials found that using smartphone apps or wearable technologies can increase daily step count and moderate-to-vigorous physical activity among people with heart disease. The analysis showed that digital tools, such as self-monitoring, feedback, and goal setting, can motivate patients to be more active.
A new study published in JACC found that women who consistently strength train showed substantially lower risk of major cardiovascular disease, particularly alongside aerobic activity and reduced sedentary time. Higher levels of resistance training were associated with lower risk of major CVD, especially myocardial infarction, with no ...
A new study suggests that moderate sitting may be beneficial for highly active adults, contradicting previous guidelines. The research found a J-shaped association between daily sitting time and health outcomes, with the lowest risk at approximately 4 hours of sitting per day.
Research in mice and human heart cells suggests that synthetic cooling agents in e-cigarettes can disrupt heart rhythm, causing abnormal beats and increased cardiovascular risk. The study's findings have implications for policymakers reviewing current rules on coolants used in vapes.
A new study by Uppsala University researchers shows that internet-based CBT can significantly reduce symptoms of stress and anxiety in women with broken-heart syndrome, a condition often triggered by extreme stress. The treatment also helps patients better cope with emotions related to their illness.
A new study reveals that obesity is reshaping the global cardiovascular disease crisis, with heart disease now peaking in people aged 50-54 rather than the elderly. The study projects over 1.37 million premature cardiovascular deaths attributed to obesity by 2050, primarily in South Asia and low-income countries.
A new AI model analyzed 30 years of EHR data to identify patients with primary aldosteronism, a common cause of high blood pressure. The model correctly flagged over 90% of cases while missing fewer than 10%, suggesting it could improve screening for this condition.
A recent study of 42,000 adults taking blood pressure medications and GLP-1s found higher rates of hypotension events, including dizziness and fainting. The study highlights a potential safety concern for patients aged 65 and older and those with diabetes.
Dr. Samantha Parker Kelleher and researchers will examine the role of postpartum hypertension on recurrent hypertensive disorders of pregnancy, such as preeclampsia and gestational hypertension. The team aims to identify ways to decrease HDP rates among mothers and develop new prevention strategies.
A new study found associations between cardiac remodeling and higher risks of breast and colorectal cancers, with left ventricular mass index linked to breast cancer risk and reduced peak left atrial strain predictive of colorectal cancer risk. The study suggests that early heart changes may serve as an early marker for identifying ind...
A new preclinical study by Amsterdam UMC researchers overturns a key assumption in the biological pacemaker field. They show that transcription factor TBX18 does not generate true pacemaker activity, while ion channel Hcn2 produces robust pacemaker function in the heart.
Researchers are investigating the role of MYRF in HLHS, a severe congenital heart defect requiring multiple surgeries. The study aims to better understand how MYRF regulates heart development, with potential implications for improved care and long-term outcomes.
A new study from Penn State College of Medicine found that excessive daytime sleepiness is associated with a higher risk of both prevalent and incident hypertension. Individuals reporting excessive daytime sleepiness had 52% higher odds of prevalent hypertension and 74% higher odds of incident hypertension compared to normal controls.
A recent study published in Nature explored how tailoring stroke rehabilitation for bilingual aphasia patients can improve recovery outcomes. An AI model called BiLex was used to create digital twins of patients, which helped identify the most effective language for therapy.
The application deadline has been extended to June 23, 2026, in two categories: Women's Health and Pharmaceutical Strategies and Innovation. The €45,000 prize fund includes six awards of €10,000, €7,500, and €5,000.
Michele Esposito, a young cardiologist, has received a K23 award from the National Heart, Lung, and Blood Institute. The award aims to develop innovative approaches for treating peripheral microvascular dysfunction in heart failure, which affects exercise tolerance.
A new analysis tracks global sugar-sweetened beverage tax adoption across 183 countries, revealing South Asia's significant lead in tax implementation. The study found that countries with higher burdens of type 2 diabetes and obesity are more likely to adopt taxes, but not necessarily those with high rates of sugary drink consumption.
Adults with both obesity and an autoimmune disease who took a GLP-1-based medication had fewer emergency department visits and lower mortality rates compared to those not taking the medication. The study analyzed data from over 26,000 adults treated in the OneFlorida+ network between 2014 and 2024.
Recent studies show finerenone preserves kidney function, reduces cardiovascular risk and improves survival across a broader range of CKD patients. Finerenone also reduces kidney failure, heart failure or cardiovascular death risk by 23-24% in non-diabetic patients.
The Phase III FIND-CKD trial found that finerenone significantly slowed kidney function decline and reduced the risk of cardiovascular-kidney outcomes in adults with non-diabetic chronic kidney disease. Finerenone also demonstrated a consistent effect across prespecified subgroups, supporting its broad applicability in these patients.
A simple, seven-second X-ray scan can accurately detect the severity of pulmonary valve regurgitation in patients with repaired Tetralogy of Fallot. The test uses dynamic chest radiography and requires minimal radiation, offering a more accessible diagnostic option for those who cannot undergo traditional methods.
Researchers at UT MD Anderson Cancer Center have made significant advances in understanding cancer biology, developing AI-powered atlas of tertiary lymphoid structures as prognostic biomarkers, and uncovering drivers of resistance to KRAS inhibitors. Additionally, they have discovered a molecular pathway that drives stressed cells to b...
Adults with lower measured glomerular filtration rates had a higher risk of all-cause mortality, kidney failure, and major adverse cardiovascular events. Lower GFR values were also associated with increased hospitalization for heart failure and acute kidney injury.
Senescent cells that stop dividing but don't die can become abnormally active, causing inflammation and instability in blood vessel plaques. The study found that losing key regulatory proteins activates the CD38 enzyme, leading to a higher risk of blood clots and cardiovascular events.
In patients with advanced chronic kidney disease at high cardiovascular risk, low-dose rivaroxaban did not reduce the composite risk of a cardiovascular outcome. Major bleeding rates were significantly higher in the low-dose rivaroxaban group compared to the placebo group.